Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2026 08:30 ET | Source: Prodeon Medical

Prodeon Medical Receives FDA 510(k) Clearance for the Urocross® Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with Benign Prostatic Hyperplasia

FDA cleared Urocross, a non-permanent BPH implant. It remodels tissue for 6 months, then is intentionally retrieved, leaving no permanent implant behind.
January 13, 2025 08:00 ET | Source: Prodeon Medical

Prodeon Medical Announces Enrollment Completion for Expander-2 Pivotal Trial

Prodeon Medical completes patient enrollment for the Expander-2 Trial, a study evaluating the Urocross Expander System for LUTS due to BPH.